Background The use of protective stoma in anterior resection (AR) is controversial. Neoadjuvant therapy, TME and laparoscopy seem to increase the rate of anastomotic dehiscences (a.d.). Patients and methods In a prospective study, 219 patients were submitted to elective open AR (109 patients), open AR+TME nerve-sparing (110 patients), 35 of which had intrasphinteric anastomosis. Fifty-five patients were treated by neoadjuvant therapy. Primary stoma was not performed. Results We had 15 (6.8%) a.d.: 5 (2.3%) major and 10 (4.4%) minor. In the five major a.d. an immediate colostomy was performed with one death. In the 10 minor the a.d. was cured conservatively. Conclusions A protective stoma is necessary in less than 10% of the patients treated with AR, so avoiding further surgery, mortality, morbidity and higher medical costs in most patients.
Protective stoma in anterior resection of the rectum: when, how and why? / Pappalardo, Giuseppe; Spoletini, Domenico; Proposito, Delia; Fabio, Giorgiano; Annamaria, Conte; Frattaroli, Fabrizio Maria. - In: SURGICAL ONCOLOGY. - ISSN 0960-7404. - STAMPA. - 16 SUPPL 1:(2007), pp. 105-108. [10.1016/j.suronc.2007.10.032]
Protective stoma in anterior resection of the rectum: when, how and why?
PAPPALARDO, Giuseppe;SPOLETINI, Domenico;PROPOSITO, Delia;FRATTAROLI, Fabrizio Maria
2007
Abstract
Background The use of protective stoma in anterior resection (AR) is controversial. Neoadjuvant therapy, TME and laparoscopy seem to increase the rate of anastomotic dehiscences (a.d.). Patients and methods In a prospective study, 219 patients were submitted to elective open AR (109 patients), open AR+TME nerve-sparing (110 patients), 35 of which had intrasphinteric anastomosis. Fifty-five patients were treated by neoadjuvant therapy. Primary stoma was not performed. Results We had 15 (6.8%) a.d.: 5 (2.3%) major and 10 (4.4%) minor. In the five major a.d. an immediate colostomy was performed with one death. In the 10 minor the a.d. was cured conservatively. Conclusions A protective stoma is necessary in less than 10% of the patients treated with AR, so avoiding further surgery, mortality, morbidity and higher medical costs in most patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.